Sebia Academy Group

Sebia is committed to improve the health of people worldwide, through innovative diagnostic solutions, services and education.

Sebia Academy aims to educate & share scientific and medical contents with our customers and is an exclusive service of advanced training courses.

The courses, aimed at technical personnel and graduates, are held by our highly trained and respected specialists and we often invite the most important opinion leaders in the industry, who present insights and analysis on the topics covered.

Our goal is the full satisfaction of the users of our systems and their continuous updating on specific topics. Sebia Academy now offers the latest value service to remain close to our customers by adding Upcoming and On-demand webinars.

Discover our Educational Program

See all resources

Impact of monoclonal antibody therapies on electrophoresis interpretation in myeloma patients

Aug. 04, 2022

Educational Webinar with Dr. Rachel WHEELER

Early detection of Multiple Myeloma: The importance of serum protein electrophoresis

Mar. 31, 2022

Educational Webinar with Dr. Julien GUILLEMAUD

Performance of HbA1c Assays in relation to clinical requirements for its use in diabetes

Oct. 15, 2021

Educational Webinar with Dr. Cas WEYKAMP

AL Amyloidosis: Role of clinical lab in diagnosis and management

Sep. 24, 2021

Educational Webinar with Prof. Giovanni PALLADINI, PhD

Hemoglobinopathy Testing: What are the Key Points a Lab Should Consider?

Sep. 08, 2021

Educational Webinar Dr. Cornelia L. Harteveld from Leiden University Medical Center

Performance of Immunotyping vs. Immunofixation for the Detection of Monoclonal Gammopathies

Sep. 08, 2021

Educational Webinar with Katie Thoren, PhD, Memorial Sloan Kettering Cancer Center

Multiple Myeloma clinical cases for diagnosis and monitoring according to latest IMWG recommendations

Aug. 30, 2021

Educational Webinar with Prof. Alessandro Gozzetti, MD, PhD

HbA1c – The Hidden Factors

Jul. 15, 2021

HbA1c is routinely used in the clinical laboratory to diagnose and monitor diabetes mellitus. Many methods have been standardized to provide precise and accurate results for normal patients. For the other common Hb variants, most of the methods are now relatively free of analytical interference.

The importance of CDT-IFCC, marker of chronic alcohol excessive consumption

Jun. 24, 2021

Educational Webinar with M. Jean Deenmamode, IFCC Working Group Chair

No resource found